BSE Live
Oct 14, 11:20Prev. Close
1698.45
Open Price
1703.40
Bid Price (Qty.)
1684.10 (3)
Offer Price (Qty.)
1688.40 (5)
NSE Live
Oct 14, 11:20Prev. Close
1706.30
Open Price
1706.30
Bid Price (Qty.)
1686.40 (3)
Offer Price (Qty.)
1687.90 (1)
Balance Sheet of Epigral (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 43.14 | 41.55 | 41.55 | 41.55 | 41.55 | |
Total Share Capital | 43.14 | 96.55 | 151.55 | 41.55 | 41.55 | |
Reserves and Surplus | 1,860.39 | 1,212.54 | 1,027.62 | 684.42 | 431.66 | |
Total Reserves and Surplus | 1,860.39 | 1,212.54 | 1,027.62 | 684.42 | 431.66 | |
Total Shareholders Funds | 1,903.53 | 1,309.09 | 1,179.17 | 725.97 | 473.21 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 448.97 | 492.04 | 434.64 | 768.14 | 340.47 | |
Deferred Tax Liabilities [Net] | 293.65 | 208.65 | 166.73 | 91.75 | 30.81 | |
Other Long Term Liabilities | 6.75 | 0.09 | 1.35 | 2.62 | 3.06 | |
Long Term Provisions | 5.80 | 4.88 | 2.72 | 2.89 | 1.63 | |
Total Non-Current Liabilities | 755.17 | 705.67 | 605.44 | 865.41 | 375.96 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 135.61 | 415.65 | 331.50 | 221.22 | 75.03 | |
Trade Payables | 185.68 | 165.28 | 110.17 | 88.11 | 73.05 | |
Other Current Liabilities | 171.13 | 198.44 | 205.81 | 222.79 | 240.47 | |
Short Term Provisions | 0.32 | 0.20 | 0.16 | 0.18 | 0.10 | |
Total Current Liabilities | 492.74 | 779.57 | 647.64 | 532.29 | 388.66 | |
Total Capital And Liabilities | 3,151.44 | 2,794.33 | 2,432.25 | 2,123.67 | 1,448.75 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 2,219.29 | 1,744.68 | 1,778.86 | 1,039.40 | 1,070.65 | |
Intangible Assets | 18.73 | 21.96 | 25.19 | 28.43 | 31.66 | |
Capital Work-In-Progress | 63.89 | 482.84 | 158.10 | 589.25 | 125.84 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 2,301.91 | 2,249.49 | 1,962.15 | 1,657.08 | 1,228.15 | |
Non-Current Investments | 20.54 | 20.57 | 20.62 | 0.05 | 0.05 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 53.75 | 22.35 | 30.04 | 19.64 | 39.26 | |
Total Non-Current Assets | 2,376.20 | 2,292.40 | 2,012.80 | 1,676.77 | 1,267.46 | |
CURRENT ASSETS | ||||||
Current Investments | 76.60 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 387.99 | 262.99 | 211.83 | 154.14 | 53.96 | |
Trade Receivables | 232.32 | 178.75 | 166.32 | 256.32 | 118.84 | |
Cash And Cash Equivalents | 22.19 | 6.80 | 15.06 | 25.04 | 0.68 | |
Short Term Loans And Advances | 0.39 | 0.48 | 0.14 | 0.23 | 0.11 | |
OtherCurrentAssets | 55.75 | 52.90 | 26.10 | 11.17 | 7.70 | |
Total Current Assets | 775.24 | 501.93 | 419.45 | 446.89 | 181.29 | |
Total Assets | 3,151.44 | 2,794.33 | 2,432.25 | 2,123.67 | 1,448.75 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 279.21 | 222.10 | 293.41 | 242.60 | 393.53 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 677.86 | 376.26 | 329.48 | 266.49 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 185.78 | 107.06 | 114.19 | 8.46 | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 20.54 | 20.57 | 20.57 | -- | 0.05 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 76.60 | -- | -- | -- | -- |
05.08.2025
Epigral Consolidated June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
05.08.2025
Epigral Standalone June 2025 Net Sales at Rs 606.54 crore, down 6.86% Y-o-Y
06.05.2025
Epigral Standalone March 2025 Net Sales at Rs 627.63 crore, up 19.63% Y-o-Y
06.05.2025
Epigral Consolidated March 2025 Net Sales at Rs 627.63 crore, up 19.63% Y-o-Y